Advertisement
Screener

Alaunos Therapeutics, Inc. (TCRT) Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months

1.5 / 5 stars · 19/64 Roast Me

Alaunos Therapeutics, Inc. Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months

Alaunos Therapeutics, Inc. (TCRT) had Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months of $896.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-05.

Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths · last filed 2020-11-05

  • 2020-09-30: Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months $896.00K.
Period endLessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months
2020-09-30$896.00K
10-Q · filed 2020-11-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02